ABN Newswire is a business newswire and press release distribution service for listed companies on stock exchanges globally. ABN Newswire distributes company announcements to the professional platforms, finance portals and syndicates important corporate news to a wide variety of news aggregators and financial news systems.
DSM N.V. (AMS:DSM) Royal DSM N.V., the global Life Sciences and Materials Sciences company headquartered in the Netherlands, today announces the following management appointment:
Luca Rosetto (1963) at present Business Unit Director Europe / Americas within the Business Group DSM Anti-Infectives, will be appointed Corporate Vice President Safety, Health, Environment and Manufacturing (CSHE&M) with effect from 1 March 2009.
In his new role as Corporate Vice President CSHE&M Luca Rosetto succeeds John Prooi, who will retire with effect from 1 March 2009.
Luca Rosetto will report to J. Zuidam, Deputy Chairman of the DSM Managing Board.
DSM - the Life Sciences and Materials Sciences Company Royal DSM N.V. creates innovative products and services in Life Sciences and Materials Sciences that contribute to the quality of life. DSM's products and services are used globally in a wide range of markets and applications, supporting a healthier, more sustainable and more enjoyable way of life. End markets include human and animal nutrition and health, personal care, pharmaceuticals, automotive, coatings and paint, electrics and electronics, life protection and housing. DSM has annual sales of almost EUR 8.8 billion and employs some 23,000 people worldwide. The company is headquartered in the Netherlands, with locations on five continents. DSM is listed on Euronext Amsterdam. More information: www.dsm.com